The expression of inducible nitric oxide synthase (iNOS) in the testis and epididymis of rats with a dihydrotestosterone (DHT) deficiency.
In our previous studies, we showed that a finasteride-induced DHT deficiency may cause changes in the morphology of the seminiferous epithelium without any morphological alteration of the epididymis. In this study, we demonstrated the constitutive immunoexpression of inducible nitric oxide synthase (iNOS) in the testis and epididymis of Wistar rats treated with finasteride for 28 days (the duration of two cycles of the seminiferous epithelium) and 56 days (the duration of one spermatogenesis). We noted that a 56-day finasteride treatment mainly caused a decrease in the level of circulating DHT, as well as a statistically insignificant decrease in the level of T. The hormone deficiency also led to a change in the iNOS immnoexpression in the testis and epididymis of the finasteride-treated rats. In vitro, DHT did not modify NO production by the epithelial cells of the caput epididymis even when stimulated with LPS and IFNgamma, but it did give rise to an increase in NO production by the epithelial cells of the cauda epididymis without the stimulation. DHT did not have a statistically significant influence on estradiol production by cultured, LPS- and IFNgamma-stimulated epithelial cells from the caput and cauda epididymis. In conclusion, our data clearly indicates that a finasterideinduced DHT deficiency intensifies the constitutive expression of iNOS in most rat testicular and epididymal cells, so it can be expected that the expression of inducible nitric oxide synthase (iNOS) could be regulated by DHT. On the other hand, the profile of the circulating DHT and T levels strongly suggests that the regulation of constitutive iNOS expression is complex and needs more detailed study.
Kolasa
Agnieszka
A
Department of Histology and Embryology, Pomeranian Medical University, Powstanców Wlkp. 72, 70-111, Szczecin, Poland. ak1712@sci.pam.szczecin.pl
Marchlewicz
Mariola
M
Kurzawa
Rafał
R
Głabowski
Wojciech
W
Trybek
Grzegorz
G
Wenda-Rózewicka
Lidia
L
Wiszniewska
Barbara
B
D000818:Animals; D013196:Dihydrotestosterone / Q000378:metabolism*; D004822:Epididymis / Q000201:enzymology*; D018120:Finasteride / Q000494:pharmacology*; D007371:Interferon-gamma / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008297:Male; D052247:Nitric Oxide Synthase Type II / Q000276:immunology / Q000378:metabolism*; D009573:Nitrites / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013737:Testis / Q000201:enzymology*
D008070:Lipopolysaccharides; D009573:Nitrites; D013196:Dihydrotestosterone; D018120:Finasteride; D007371:Interferon-gamma; D052247:Nitric Oxide Synthase Type II